Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old With Bipolar I, Bipolar II and Bipolar Spectrum Disorder
Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 26 Jul 2018
Price : $35 *
At a glance
- Drugs Lurasidone (Primary)
- Indications Bipolar disorders; Bipolar I disorders; Bipolar II disorders; Manic episodes
- Focus Therapeutic Use
- 18 Jul 2018 Status changed from suspended to withdrawn prior to enrolment.
- 12 Feb 2016 Planned initiation date changed from 1 Dec 2015 to 1 Jan 2017 as reported by ClinicalTrials.gov record.
- 12 Feb 2016 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov record.